Next Article in Journal
The Novel HDAC Inhibitor OBP-801 Promotes MHC Class I Presentation Through LMP2 Upregulation, Enhancing the PD-1-Targeting Therapy in Clear Cell Renal Cell Carcinoma
Previous Article in Journal
Immune-Modified Glasgow Prognostic Score Predicts Therapeutic Effect of Pembrolizumab in Recurrent and Metastatic Head and Neck Cancer
 
 
Article

Article Versions Notes

Cancers 2024, 16(23), 4057; https://doi.org/10.3390/cancers16234057
Action Date Notes Link
article html file updated 4 January 2026 20:17 CET Update https://www.mdpi.com/2072-6694/16/23/4057/html
article html file updated 14 September 2025 16:57 CEST Update -
article html file updated 28 August 2025 04:11 CEST Update -
article html file updated 1 July 2025 19:47 CEST Update -
article html file updated 4 December 2024 05:06 CET Original file -
article supplementary file uploaded. 4 December 2024 05:05 CET - https://www.mdpi.com/2072-6694/16/23/4057#supplementary
article pdf uploaded. 4 December 2024 05:05 CET Version of Record https://www.mdpi.com/2072-6694/16/23/4057/pdf
article xml uploaded. 4 December 2024 05:05 CET Update https://www.mdpi.com/2072-6694/16/23/4057/xml
article xml file uploaded 4 December 2024 05:05 CET Original file -
Back to TopTop